Aluronix Technologies Inc. Begins Production of Enhanced Hyaluronic Acid Products Patented SSRB Technology

Shortly after announcing its SSRB technology patent, Aluronix Technologies Inc. has started production of a line of enhanced Hyaluronic Acid products. The patented formula combines Hyaluronan with other bioactive ingredients to allow the body to (1) more efficiently metabolize it, and (2) absorb it where it’s needed most.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Aluronix Technologies Inc.

Aluronix Technologies Inc.

Each of the products in Aluronix’s line of hyaluronan supplements has been specially blended with other bioactive ingredients to target specific bodily systems.

Montreal, QC (PRWEB) January 17, 2014

Aluronix Technologies Inc. has started production of its line of advanced Hyaluronic Acid health products using its patented SSRB technology. Specially formulated to be more effective than any other Hyaluronan compound on the market, the product line will be produced at a state of the art production facility in Switzerland, and is expected to be available for distribution in the US and Canada in the coming months.

With other hyaluronic acid health products, the body normally absorbs only a fraction of the orally delivered dosage. Aluronix’s SSRB patent, however, increases the bioavailability of hyaluronan compounds up to 90% and higher, by stabilizing the hyaluronan at the molecular level, prolonging its life span in the body. This offers consumers more of the compound’s health benefits, as well as a better cost-savings.

“What we’ve done here is to really unlock all the different potentials of Hyaluronic Acid, and developed a method of focusing its delivery,” said Dr. Polyak. “And in the coming months, we’ll be able to share this breakthrough with American and Canadian consumers in the form of several unparalleled Hyaluronic Acid products.”

Each of the products in Aluronix’s line of hyaluronan supplements has been specially blended with other bioactive ingredients to target specific bodily systems. The result is a line of hyaluronic acid products that offers both greater value and more health benefits than more generic Hyaluronan products on the market.

The company’s patented SSRB technology also enhances the bioavailability of these other bioactive ingredients. Whereas different bodily systems would normally compete with each other to absorb these bioactives, Aluronix’s SSRB patent stabilizes them on a molecular level with hyaluronic acid which ensures that the bioactives are delivered to where they are needed most.

Aluronix Technologies will soon launch an ecommerce portal where consumers will be able to order the right hyaluronic acid product for them directly. The company is also currently establishing distribution partnerships throughout North America. Distributors and Retailers interested in obtaining more information on Aluronix’s products or placing an advance order can do so on the company’s website.

About Aluronix Tecnologies Inc.
Based in Montreal, Quebec, Canada, Aluronix Technologies Inc. is committed to the manufacturing and distribution of the most advanced health supplements possible. Through advanced research and development, its laboratories are continually developing new methods for enhancing the benefits and effectiveness of different health products.

Contact Info
Felix Polyak
Aluronix Technologies Inc.
+1.514.416.0503
press(at)aluronix(dot)com
http://aluronix.com/


Contact

Past News Releases Group Rss Subscribe